Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Clinical trial NCT06274788 · RECRUITING
Trial details
- NCT number
- NCT06274788
- Sponsor
- Fresenius Kabi
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-12-15
- Primary completion
- 2028-04-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.